Funding for early phase clinical trials of natural products, including botanicals and dietary supplements, to assess impact on target engagement and patient outcomes.
This grant supports mid-phase clinical trials of promising natural products for determining optimal doses/formulations or patient responses, excluding cancer trials.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
Accelerating precision probiotic interventions by identifying subgroups of responders through unique biological patterns, aiming to enhance clinical outcomes.
This grant funds innovative natural history studies to improve understanding and support medical product development for rare diseases with unmet needs.